Related references
Note: Only part of the references are listed.Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence
Roxanne Saucier et al.
DRUG SAFETY (2018)
Buprenorphine alone or with naloxone: Which is safer?
Erin Kelty et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
Time-dependent neuronal changes associated with craving in opioid dependence: an fMRI study
Anna Murphy et al.
ADDICTION BIOLOGY (2018)
Abuse liability of intravenous buprenorphine vs. buprenorphine/naloxone: Importance of absolute naloxone amount
Jermaine D. Jones et al.
DRUG AND ALCOHOL DEPENDENCE (2017)
How fast and how often: The pharmacokinetics of drug use are decisive in addiction
Florence Allain et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2015)
Abuse potential of intranasal buprenorphine versus buprenorphine/naloxone in buprenorphine-maintained heroin users
Jermaine D. Jones et al.
ADDICTION BIOLOGY (2015)
Urine naloxone concentration at different phases of buprenorphine maintenance treatment
Pertti Heikman et al.
DRUG TESTING AND ANALYSIS (2014)
A Review of Buprenorphine Diversion and Misuse: The Current Evidence Base and Experiences From Around the World
Michelle R. Lofwall et al.
JOURNAL OF ADDICTION MEDICINE (2014)
The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers
Lisa S. Middleton et al.
ADDICTION (2011)
Post-marketing surveillance of buprenorphine-naloxone in Australia: Diversion, injection and adherence with supervised dosing
Briony Larance et al.
DRUG AND ALCOHOL DEPENDENCE (2011)
Uniform assessment and ranking of opioid Mu receptor binding constants for selected opioid drugs
Donna A. Volpe et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2011)
Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers
Sandra D. Comer et al.
ADDICTION (2010)
Injection of buprenorphine and buprenorphine/naloxone tablets in Malaysia
B. Vicknasingam et al.
DRUG AND ALCOHOL DEPENDENCE (2010)
Acute effects of intramuscular and sublingual buprenorphine and buprenorphine/naloxone in non-dependent opioid abusers
Angela N. Duke et al.
PSYCHOPHARMACOLOGY (2010)
Lack of Reduction in Buprenorphine Injection After Introduction of Co-Formulated Buprenorphine/Naloxone to the Malaysian Market
R. Douglas Bruce et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2009)
被撤回的出版物: High-Affinity Naloxone Binding to Filamin A Prevents Mu Opioid Receptor-Gs Coupling Underlying Opioid Tolerance and Dependence (Retracted article. See vol. 17, 2022)
Hoau-Yan Wang et al.
PLOS ONE (2008)
Mechanism-based pharmacokinetic-pharmacodynamic modelling of the reversal of buprenorphine-induced respiratory depression by naloxone - A study in healthy volunteers
Ashraf Yassen et al.
CLINICAL PHARMACOKINETICS (2007)
Cocaine craving, euphoria, and self-administration: A preliminary study of the effect of catecholamine precursor depletion
M Leyton et al.
BEHAVIORAL NEUROSCIENCE (2005)
Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and G beta gamma signaling
HY Wang et al.
NEUROSCIENCE (2005)
Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist
CL Neilan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Intravenous use of prescribed sublingual buprenorphine tablets by drug users receiving maintenance therapy in France
G Vidal-Trecan et al.
DRUG AND ALCOHOL DEPENDENCE (2003)
Self-administration of intravenous buprenorphine and the buprenorphine/naloxone combination by recently detoxified heroin abusers
SD Comer et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Effects of buprenorphine/naloxone in opioid-dependent humans
KB Stoller et al.
PSYCHOPHARMACOLOGY (2001)
Share Paper
